DxFLEX 10C Clinical Study

Official Title

DxFLEX ClearLLab 10C US-IVD Clinical Study Protocol - Clinical Laboratory


A multi-centre method comparison study is designed per CLSI-EP09 A3. This study compares the qualitative immunophenotype agreement between DxFLEX and Navios EX to demonstrate the accuracy of the DxFLEX-10C system. A series of precision studies will be conducted with each focusing on different aspects of the DxFLEX-10C system.

Trial Description

Primary Outcome:

  • Flow immunophenotyped normal and abnormal

View this trial on ClinicalTrials.gov

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society